目前放射治疗仍为治疗局部晚期宫颈癌的主要方法。由于宫颈癌的分期缺乏敏感的影像学标准,因此,手术了解其病变的范围和进行分期,已逐渐被接受并作为制定治疗方案的标准。放疗的总剂量、剂量分割、放射野的大小均与患者的严重放射并发症及生存率相关。放射增敏对生存率也有影响。 1971～1991年对189例患者行治疗前手术分期,按FIGO临床分期:Ⅰ期7例,Ⅱ期 91例,Ⅲ期 Radiotherapy is still the main method for treating locally advanced cervical cancer. Because of the lack of sensitive imaging criteria for the stage of cervical cancer, it is gradually accepted that surgery to understand the extent of its lesions and the staging, as a standard for the development of treatment programs. The total radiation dose, dose split, and size of the radiation field were related to the patient’s severe radiation complications and survival. Radiosensitization also has an impact on survival. From 1971 to 1991, 189 patients were treated before surgery, according to FIGO clinical staging: 7 patients in phase I, 91 patients in phase II, phase III